Abstract
Neurogenetic tests are increasingly requested by clinical neurologists without any formal training in clinical genetics. The aim of our study was to assess the documentation of consent and disclosure of genetic test results in a large regional clinical neuroscience centre. Documentation of some form of consent was evident in only 26/132 (20 %) of tests. However, the higher proportion of both positive and negative results disclosed (50/132, 38 %) suggest that the former figure may underestimate actual rates of undocumented consent within the clinical setting. Our findings highlight the need for a review of established practices surrounding consent in clinical neurology.
References
Royal College of Physicians, Royal College of Pathologists and British Society for Human Genetics (2011) Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information, 2nd edn. Report of the Joint Committee on Medical Genetics. London: RCP, RCPath
(2003) Our inheritance, our future. Realising the potential of genetics in the NHS. The Stationary Office
European Society of Human Genetics (2010) Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genetics 18(12):1271–1273
Vance JM, Tekin D (2011) Genomic medicine and neurology. Continuum 17:249–267
PHG Foundation (2011) Genetics and mainstream medicine. ISBN 978-1-907198-07-6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lo, C., Martindale, J., Hadjivassiliou, M. et al. The documentation of consent and disclosure of neurogenetic testing outside clinical genetics. Neurogenetics 15, 19–21 (2014). https://doi.org/10.1007/s10048-014-0391-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-014-0391-3